Fulgent Genetics, Inc. Quarterly Debt-to-equity in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Fulgent Genetics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2017 to Q3 2024.
  • Fulgent Genetics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 8.98 %, a 10.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 8.98 +0.83 +10.2% Sep 30, 2024
Q2 2024 8.7 +0.03 +0.35% Jun 30, 2024
Q1 2024 8.22 -1.55 -15.9% Mar 31, 2024
Q4 2023 8.09 -2.47 -23.4% Dec 31, 2023
Q3 2023 8.16 -2.56 -23.9% Sep 30, 2023
Q2 2023 8.68 -3.32 -27.7% Jun 30, 2023
Q1 2023 9.77 -2.8 -22.3% Mar 31, 2023
Q4 2022 10.6 -4.78 -31.2% Dec 31, 2022
Q3 2022 10.7 -7.89 -42.4% Sep 30, 2022
Q2 2022 12 -8.97 -42.8% Jun 30, 2022
Q1 2022 12.6 -11.6 -48% Mar 31, 2022
Q4 2021 15.3 -7.18 -31.9% Dec 31, 2021
Q3 2021 18.6 -0.37 -1.95% Sep 30, 2021
Q2 2021 21 +11.4 +118% Jun 30, 2021
Q1 2021 24.2 +14.6 +153% Mar 31, 2021
Q4 2020 22.5 +12.6 +128% Dec 31, 2020
Q3 2020 19 +9.14 +92.8% Sep 30, 2020
Q2 2020 9.62 +1.81 +23.2% Jun 30, 2020
Q1 2020 9.58 +2.94 +44.3% Mar 31, 2020
Q4 2019 9.89 +4.91 +98.6% Dec 31, 2019
Q3 2019 9.84 +4.82 +95.9% Sep 30, 2019
Q2 2019 7.81 +2.32 +42.3% Jun 30, 2019
Q1 2019 6.64 +1.19 +21.8% Mar 31, 2019
Q4 2018 4.98 -0.92 -15.6% Dec 31, 2018
Q3 2018 5.03 -1.11 -18.1% Sep 30, 2018
Q2 2018 5.49 -3.08 -35.9% Jun 30, 2018
Q1 2018 5.45 Mar 31, 2018
Q4 2017 5.9 Dec 31, 2017
Q3 2017 6.14 Sep 30, 2017
Q2 2017 8.57 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.